Pulmonary Toxicity After Long-Term Treatment With Lenalidomide in Two Myeloma Patients

European Respiratory Review - United Kingdom
doi 10.1183/09059180.00001912
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Efficacy and Safety of Long-Term Treatment With Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2014English

Immortal Time Bias in Retrospective Analysis: Comment on ‘Efficacy and Safety of Long-Term Treatment With Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma’

Blood Cancer Journal
OncologyHematology
2015English

Cardiac Toxicity Secondary to Long Term Treatment With Chloroquine

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2001English

Low-Dose Lenalidomide and Dexamethasone Combination Treatment in Elderly Patients With Relapsed and Refractory Multiple Myeloma

Hematology
Hematology
2016English

Long-Term Treatment With Sildenafil in Chronic Thromboembolic Pulmonary Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2007English

Update on the Role of Lenalidomide in Patients With Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2018English

GRP-024 Antithrombotic Prophylaxis in Patients With Multiple Myeloma Being Treated With Lenalidomide

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Long-Term Treatment of C1 Inhibitor Deficiency With Ɛ-Aminocaproic Acid in Two Patients

Mayo Clinic Proceedings
Medicine
1996English

Toxicity-Reduced, Myeloablative Allograft Followed by Lenalidomide Maintenance as Salvage Therapy for Refractory/Relapsed Myeloma Patients

Bone Marrow Transplantation
TransplantationHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy